BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 28423653)

  • 1. A novel microRNA signature predicts survival in stomach adenocarcinoma.
    Ding B; Gao X; Li H; Liu L; Hao X
    Oncotarget; 2017 Apr; 8(17):28144-28153. PubMed ID: 28423653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of microRNA expression profiles reveals a 5‑microRNA prognostic signature for predicting overall survival time in patients with gastric adenocarcinoma.
    Zhao R; Zhao L; Xu X; Xu H
    Oncol Rep; 2019 May; 41(5):2775-2789. PubMed ID: 30864737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Five-gene Signature based on MicroRNA for Predicting Prognosis and Immunotherapy in Stomach Adenocarcinoma.
    Wang T; Chen P; Li T; Li J; Zhao D; Meng F; Zhao Y; Zheng Z; Liu X
    Curr Med Chem; 2024; 31(17):2378-2399. PubMed ID: 38310388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma.
    Gao X; Wu Y; Yu W; Li H
    Oncotarget; 2016 Dec; 7(49):81670-81679. PubMed ID: 27835574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma.
    Li X; Shi Y; Yin Z; Xue X; Zhou B
    J Transl Med; 2014 Jun; 12():159. PubMed ID: 24893932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA signature predicts survival in papillary thyroid carcinoma.
    Chengfeng X; Gengming C; Junjia Z; Yunxia L
    J Cell Biochem; 2019 Oct; 120(10):17050-17058. PubMed ID: 31099134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
    Ren N; Liang B; Li Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of an immune-related gene prognostic model for stomach adenocarcinoma.
    Wu M; Xia Y; Wang Y; Fan F; Li X; Song J; Ding J
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33112406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome‑scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.
    Wei HT; Guo EN; Liao XW; Chen LS; Wang JL; Ni M; Liang C
    Oncol Rep; 2018 Oct; 40(4):1947-1958. PubMed ID: 30066920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically applicable 53-Gene prognostic assay predicts chemotherapy benefit in gastric cancer: A multicenter study.
    Zhu L; Wang H; Jiang C; Li W; Zhai S; Cai X; Wang X; Liao L; Tao F; Jin D; Chen G; Xia Y; Mao JH; Li B; Wang P; Hang B
    EBioMedicine; 2020 Nov; 61():103023. PubMed ID: 33069062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Five-microRNA Signature for Survival Prognosis in Pancreatic Adenocarcinoma based on TCGA Data.
    Shi XH; Li X; Zhang H; He RZ; Zhao Y; Zhou M; Pan ST; Zhao CL; Feng YC; Wang M; Guo XJ; Qin RY
    Sci Rep; 2018 May; 8(1):7638. PubMed ID: 29769534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a novel prognostic signature in gastric adenocarcinoma.
    Mao R; Wang Z; Zhang Y; Chen Y; Liu Q; Zhang T; Liu Y
    Aging (Albany NY); 2020 Nov; 12(21):22233-22252. PubMed ID: 33188157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.
    Matsui D; Zaidi AH; Martin SA; Omstead AN; Kosovec JE; Huleihel L; Saldin LT; DiCarlo C; Silverman JF; Hoppo T; Finley GG; Badylak SF; Kelly RJ; Jobe BA
    Oncotarget; 2016 Dec; 7(49):81281-81291. PubMed ID: 27793030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of expression profile of miRNA in stomach adenocarcinoma.
    Huo Q
    J BUON; 2017; 22(5):1154-1159. PubMed ID: 29135097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a Four-miRNA Panel as a Biomarker for the Diagnosis of Stomach Adenocarcinoma.
    Chen X; Li X; Peng X; Zhang C; Liu K; Huang G; Lai Y
    Dis Markers; 2020; 2020():8880937. PubMed ID: 33224315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel microRNA signature predicts survival in liver hepatocellular carcinoma after hepatectomy.
    Fu Q; Yang F; Xiang T; Huai G; Yang X; Wei L; Yang H; Deng S
    Sci Rep; 2018 May; 8(1):7933. PubMed ID: 29785036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upgrading the Repertoire of miRNAs in Gastric Adenocarcinoma to Provide a New Resource for Biomarker Discovery.
    Pewarchuk ME; Barros-Filho MC; Minatel BC; Cohn DE; Guisier F; Sage AP; Marshall EA; Stewart GL; Rock LD; Garnis C; Lam WL
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.